Please use this identifier to cite or link to this item: http://earsiv.odu.edu.tr:8080/xmlui/handle/11489/4445
Full metadata record
DC FieldValueLanguage
dc.contributor.authorYazar, Tamer-
dc.contributor.authorYazar, Hulya Olgun-
dc.date.accessioned2024-03-15T11:14:29Z-
dc.date.available2024-03-15T11:14:29Z-
dc.date.issued2019-
dc.identifier.citationYazar, T., Yazar, HO. (2019). Prevalance of sarcopenia according to decade. Clin. Nutr. ESPEN, 29, 137-141. https://doi.org/10.1016/j.clnesp.2018.11.005en_US
dc.identifier.issn2405-4577-
dc.identifier.urihttp://dx.doi.org/10.1016/j.clnesp.2018.11.005-
dc.identifier.urihttps://www.webofscience.com/wos/woscc/full-record/WOS:000456061800021-
dc.identifier.urihttp://earsiv.odu.edu.tr:8080/xmlui/handle/11489/4445-
dc.descriptionWoS Categories: Nutrition & Dieteticsen_US
dc.descriptionWeb of Science Index: Emerging Sources Citation Index (ESCI)en_US
dc.descriptionResearch Areas: Nutrition & Dieteticsen_US
dc.description.abstractAim: Our study aimed to identify Skeletal Muscle Mass Index (SMMI) cut-off values for sarcopenia diagnosis in our population and determine the prevalance of sarcopenia, and to collect data about reducing the disease load. Method: The study was completed with 515 volunteers divided into groups based on ages of 18-39 years, 40-49 years, 50-59 years, 60-69 years, 70-79 years and 80 years and older. All groups had SMMI, muscle strenght physical performance assessed, with sarcopenia diagnosis made using the European Working Group on Sarcopenia in Older People (EWGSOP) diagnostic criteria. Results: Together with advancing decades, there were significant reductions observed in SMMI, hand grip test (HGT) and 4-m walking test (4MWT) values. For females and males, the reduction in HGT and 4MWT values began after 50 years of age, while the reduction in SMMI began after 70 years for males and after 60 years for females. The prevalance of sarcopenia in the 40-49, 50-59, 60-69, 70-79 and 80 years plus age intervals were identified as 7%, 10.6%, 15.4%, 21.2% and 36.5%, respectively. Conclusion: Identification of sarcopenia prevalence in our population is important due to limitations of treatment administered after diagnosis is made. (C) 2018 European Society for Clinical Nutrition and Metabolism. Published by Elsevier Ltd. All rights reserved.en_US
dc.language.isoengen_US
dc.publisherELSEVIER SCIENCE BV-AMSTERDAMen_US
dc.relation.isversionof10.1016/j.clnesp.2018.11.005en_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectSarcopenia, Skeletal muscle mass index, Hand grip test, 4 m walking testen_US
dc.subjectEWGSOP DEFINITION, BODY-COMPOSITION, PREVALENCE, EPIDEMIOLOGY, DIAGNOSIS, DYNAPENIA, ADULTS, SCALE, MASSen_US
dc.titlePrevalance of sarcopenia according to decadeen_US
dc.typearticleen_US
dc.relation.journalCLINICAL NUTRITION ESPENen_US
dc.contributor.departmentOrdu Üniversitesien_US
dc.contributor.authorID0000-0003-3054-6613en_US
dc.contributor.authorID0000-0003-2768-6092en_US
dc.identifier.volume29en_US
dc.identifier.startpage137en_US
dc.identifier.endpage141en_US
Appears in Collections:Dahili Tıp Bilimleri

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.